InnovationRx provides you with a curated collection of healthcare news every week. To receive it directly in your inbox, subscribe here.
Doctors are continuously investigating the phenomenon of long Covid, which continues to affect hundreds of thousands, if not millions, of individuals who contracted the virus during the pandemic. The persistent symptoms often result in patients enduring considerable suffering, with limited treatment options available. However, there may be a glimmer of hope: researchers at the Fred Hutchinson Cancer Center and the Allen Institute have made a breakthrough discovery, suggesting that an overactive inflammatory response may be at the root of long Covid. This finding builds upon previous research that also indicated a connection between inflammation and long Covid. The type of inflammation observed is similar to that seen in rheumatoid arthritis, suggesting that treatments used for this condition might be beneficial for long Covid patients experiencing this type of inflammation.
According to Fred Hutchinson infectious disease director Julie McElrath, “We hope these findings provide insights into long Covid that may guide future therapeutic approaches.”
Lawsuits Alleging Vendor Fraud Fail to Deter Andreessen Horowitz’s Support for Former CEO’s New Venture
Munjal Shah, the former CEO of Health IQ, has received continued backing from venture firm Andreessen Horowitz, despite allegations of millions in unpaid invoices, significant debt, and an ongoing lawsuit accusing him of fraud.
For more details, read here.
Pipeline & Deal Updates
Chikungunya Vaccine: A promising late-stage trial featured in the Lancet suggests the possible development of a vaccine for chikungunya, a mosquito-borne infection with symptoms similar to those of dengue and Zika.
Divestment: Walgreens, a leading drugstore chain, has sold its remaining stake in home infusion services provider Option Care Health for approximately $330 million.
Neurology: Recursion announced the full enrollment of its phase two trial for REC-994, an AI-developed small molecule for Cerebral Cavernous Malformation. Both the FDA and European Medicines Agency have granted it Orphan Drug designation.
Fertility: Oova, the creator of a fertility kit that helps women identify optimal conception times, has successfully raised $10.3 million in a series A funding round.
Genetic Medicine: Kate Therapeutics, a newly emerged company, has raised a substantial $51 million series A funding round co-led by Versant Ventures and Westlake Village BioPartners. The company aims to develop genetic medicines to address heart and muscle diseases.
Taking ‘Smart Drugs’ Without ADHD Decreases Productivity, Study Finds
A recent study reveals that using prescription stimulants or “smart” drugs, such as Ritalin and Adderall, to enhance productivity without having attention-deficit/hyperactivity disorder actually decreases overall productivity and increases the time required to complete tasks.
To learn more, click here.
Other Healthcare News
Taurine, a nutrient found in popular energy drinks like Red Bull, could potentially slow down aging, according to a recent study.
The White House Drug Czar, Dr. Rahul Gupta, warns that without the implementation of proposed intervention initiatives by the Biden Administration, opioid deaths could rise to approximately 165,000 by 2025.
A new study suggests that light-to-moderate drinking may improve long-term heart function by reducing stress.
Ride-share company Uber plans to expand its services by delivering healthy food, groceries, and over-the-counter products for healthcare providers to send to patients using their ride-share platform.
Health insurance companies are experiencing a decline in stock prices due to increased payouts for patients receiving minor surgeries that were delayed during the pandemic.
Across Forbes
An Analysis of Taylor Swift Vs. Beyoncé: How These Superstars Compare
California’s Fully Solar-Powered $100 Billion Electric Bullet Train
Meet the Enigmatic Executive, ‘Heina’ Chen, Controlling Finances at Binance
Follow Google News
Denial of responsibility! TechCodex is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
Jessica Irvine is a tech enthusiast specializing in gadgets. From smart home devices to cutting-edge electronics, Jessica explores the world of consumer tech, offering readers comprehensive reviews, hands-on experiences, and expert insights into the coolest and most innovative gadgets on the market.
